PMX-DHP Therapy for Dyspnea and Deoxygenation in Severe COVID-19 Pneumonia: A Case Series

Hypercytokinemia induced by coronavirus disease-19 (COVID-19) is associated with severe pulmonary involvement, which may lead to respiratory failure. These conditions play an important role in the worsening of clinical symptoms in patients with severe COVID-19. There is no established treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwana, Tsukasa, Kinoshita, Kosaku, Hirabayashi, Marina, Ihara, Shingo, Sawada, Nami, Mutoh, Tomokazu, Yamaguchi, Junko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040694/
https://www.ncbi.nlm.nih.gov/pubmed/33854342
http://dx.doi.org/10.2147/IDR.S299023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040694/
https://www.ncbi.nlm.nih.gov/pubmed/33854342
http://dx.doi.org/10.2147/IDR.S299023

Ejemplares similares